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Introduction Reliable predictors of poor clinical outcome despite successful 
revascularization might help select patients with acute ischemic stroke for 
thrombectomy. We sought to determine whether baseline Alberta Stroke 
Program Early CT Score (ASPECTS) applied to CT angiography source images 
(CTA-SI) is useful in predicting futile recanalization. Methods Data are from the 
FUN-TPA study registry (ClinicalTrials.gov; NCT02164357) including patients 
with acute ischemic stroke due to proximal arterial occlusion in anterior 
circulation, undergoing reperfusion therapies. Baseline non-contrast CT and 
CTA-SI-ASPECTS, timelapse to image acquisition, occurrence, and timing of 
recanalization were recorded. Outcome measures were NIHSS at 24 h, 
symptomatic intracranial hemorrhage, modified Rankin scale score, and 
mortality at 90 days. Futile recanalization was defined when successful 
recanalization was associated with poor functional outcome (death or disability). 
Results Included were 110 patients, baseline NIHSS 17 (IQR 12; 20), treated 
with intravenous thrombolysis (IVT; 45 %), primary mechanical thrombectomy 
(MT; 16 %), or combined IVT+MT (39 %). Recanalization rate was 71 %, 
median delay of 287 min (225; 357). Recanalization was futile in 28 % of cases. 
In an adjusted model, baseline CTA-SI-ASPECTS was inversely related to the 
odds of futile recanalization (OR 0.5; 95 % CI 0.3–0.7), whereas NCCT-
ASPECTS was not (OR 0.8; 95 % CI 0.5–1.2). A score ≤5 in CTA-SIASPECTS 
was the best cut-off to predict futile recanalization (sensitivity 35 %; specificity 
97 %; positive predictive value 86 %; negative predictive value 77 %). 
Conclusions CTA-SI-ASPECTS strongly predicts futile recanalization and could 
be a valuable tool for treatment decisions regarding the indication of 
revascularization therapies. 
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Introduction 
Early recanalization of the occluded vessel is crucial in improving the prognosis 
of acute ischemic stroke. However, despite achieving successful and prompt 
recanalization, intravenous thrombolysis (IVT) or mechanical thrombectomy 
(MT) fail to improve outcomes in a subset of patients; rates of futile 
recanalization occurring in up to 50 % of cases. Factors such as older age, high 
initial NIHSS score, and longer delay to treatment have been identified as 
predictors of futile recanalization [1, 2]. The Alberta Stroke Program Early CT 
Score (ASPECTS) [3] from baseline non-contrast CT (NCCT) is a predictor of 
outcome; scores 0 to 4 being proposed as a marker of futile recanalization [4, 
5]. However, the usefulness of this score for treatment decisions has been 
debated as it has modest inter-rater reliability, and the majority of recent trials of 
MT excluded patients with poorer baseline ASPECTS score [6]. ASPECTS on 
CT angiography source images (CTA-SIASPECTS) has been shown to be a 
more accurate predictor of outcome and final infarct volume in acute ischemic 
stroke [7, 8]. CTA is recommended for the assessment of site of occlusion and 
vessel anatomy of acute stroke patients who are potential candidates for 
endovascular treatment [9], CTA data being available in the majority of these 
patients during their initial evaluation. The aim of this study is to assess whether 
baseline CTA-SI-ASPECTS might help predict response to treatment and can 
reliably predict futile recanalization in patients undergoing reperfusion therapies; 
the intention being to find a reliable tool for treatment decision making. 
Materials and methods 
Cohort data were from the FUN-TPA study registry (ClinicalTrials.gov; 
NCT02164357). This is a prospective, observational, multicentered study 
designed to assess the safety of primary MT using stent retrievers, compared to 
a standard IVT or IVT+MT, for patients with acute ischemic stroke due to 
proximal intracranial artery occlusion. Initiation of treatment (whatever IVTor 
primary MT) is needed to be within 4.5 h from symptom onset. Assessment of 
recanalization by transcranial Doppler, CTA, or angiography (the latter in 
patients undergoing MT) was mandatory within the first 6 h. 
The study received the approval of the Ethics Committees of all the participating 
centers and was authorized by the Spanish Agency for Drugs and Health 
Products (Agencia Española de Medicamentos y Productos Sanitarios; 
AEMPS). Patients provided written informed consent to participation in the 
study. 
Included in this current sub-study were consecutive patients with intracranial 
vessel occlusion confirmed prior to any treatment by CTA in which ASPECTS 
scoring was available. 
Patients received standard IVT or primary MT as first choice when there were 
any contraindications for IVT and were considered for MT after IVT if arterial 
occlusion persisted within the time window of opportunity. 
All diagnostic and therapeutic procedures were performed according to clinical 
protocols that follow current guidelines, adhered to by all the participating stroke 
centers [10, 11]. Our protocol did not include imaging selection criteria based on 
multimodal imaging (such as CT perfusion or MRI). Patients with signs of 
extensive lesions on baseline NCCT were excluded from treatment. 
Image acquisition On admission, NCCT and CTA were obtained on a 64-slice 
spiral CT scanner using standardized protocols. CTAwas performed following 
injection of a bolus (50–60 mL) of contrast medium (4 mL/s) in an antebrachial 
vein. An automated system for image acquisition triggered by the appearance of 
contrast in the ascending aorta was used (Sure Start, Toshiba). 
Acquisition was performed by slicing every 0.5 mm to permit subsequent 
multidimensional image reconstruction. Area of coverage spanned from the 
aortic arch to the vertex. 
Imaging parameters for the aims of the study were measured retrospectively by 
independent neuroradiologists experienced in the interpretation of CTscans in 
acute stroke. These investigators were blinded with respect to patient clinical 
data (except for the side of neurological involvement) and to outcomes. 
The data collected included the following: demographics, risk factors, clinical 
severity on admission according to the National Institute of Health Stroke Scale 
(NIHSS), site of occlusion, treatment received, time lapse from symptom onset 
to diagnostic, and therapeutic procedures, recanalization achieved (or not) and 
time lapse to recanalization, when applicable. 
Vessel occlusion or recanalizationwas defined according to the thrombolysis in 
brain ischemia (TIBI) grading system [12], using transcranial ultrasound 
assessment, and according to the thrombolysis in cerebral infarction (TICI) 
grading system in angiography [13]. Successful recanalization was considered 
as TIBI 4 or 5 and TICI 2b or 3. 
Early ischemic changes such as focal hypo-attenuation, loss of gray-white 
matter differentiation, and sulci effacement were quantified using the ASPECTS 
scoring [3] in baseline NCCT. In CTA-SI, regions of diminished contrast 
enhancement of the parenchyma relative to the contralateral hemisphere were 
scored as abnormal [7]. Absence of vessel enhancement in the affected areas 
was also taken into account. 
Outcome measures were symptomatic intracerebral hemorrhage (SICH), 
defined as a parenchymal hemorrhage associated with a neurological 
deterioration of ≥4 points from the lowest NIHSS from baseline, or leading to 
death, NIHSS at 24 h, mRS score, and mortality at 90 days. Good outcome was 
considered when independence was achieved (mRS 0–2). 
Futile recanalization was considered when successful recanalization was 
obtained, but there was a poor outcome at 90 days (i.e., mRS was 3–6). Since 
the pre-specified inclusion criteria imply severe deficit, recovery of ability to walk 
without assistance, despite partial dependency (i.e., mRS score 3), can be 
considered as an acceptable outcome. As such, a secondary analysis was 
performed taking mRS scores of 4–6 as poor outcomes. 
Data analyses 
Data are expressed as median and the inter-quartile ranges (IQRs) for 
continuous variables, or as absolute and relative frequencies for categorical 
variables. NCCT-ASPECTS and CTA-SI-ASPECTS as a function of time from 
symptom onset to CT acquisition are graphically displayed as scatter plots. 
Univariate comparisons between futile and useful recanalization were made 
using the Fisher exact test for categorical variables and the Mann-Whitney U 
test for continuous variables. 
The relationships of radiological parameters and clinical data vs. outcomes and 
futile recanalization were analyzed with univariate and multivariate backward 
stepwise logistic regression models. Variables considered in the multivariate 
models were NCCT-ASPECTS as well as CTI-SI-ASPECTS, those identified as 
prognostic factors in previous studies—age, baseline NIHSS, site of occlusion, 
time lapse to recanalization—and those that were significant in the univariate 
comparisons. 
The AUROC curve was used to evaluate the discriminative function of the 
model; the optimum cut-off point being that which had maximum specificity (Sp) 
plus sensitivity (Se). All analyses were performed with the Stata/SE 12.1 
statistical package (StataCorp LP, USA). 
Results 
Between May 2012 and May 2014, we recorded data from 110 patients who 
fulfilled all the inclusion criteria. Sites of occlusion were as follows: intracranial 
internal carotid artery (ICA) 9 (8 %), bifurcation of the ICA (T-thrombus) 16 (14.5 
%), M1 segment of the middle cerebral artery (MCA) 58 (53 %), and MCA-M2 
segment 22 (20 %). 
There were five (4.5 %) cervical ICA and M1 segment tandem occlusions. Data 
on NCCT-ASPECTS were available from 105 patients and CTA-SI-ASPECTS 
from 77 patients. IVT was administered in 92 patients. All these patients were 
monitored for recanalization within 6 h from symptom onset, as pre-specified, 
and 65 of them did not achieve recanalization: 43 had MT following IVT, 9 were 
excluded for MT due to radiological signs of established lesion in a second CT 
scan, and 13 due to medical contraindications or technical difficulties associated 
with the procedure. Primary MT was performed in 18 patients due to 
contraindications for IVT. Characteristics of the cohort are summarized in 
Table 1. NCCT-ASPECTS and CTA-SI-ASPECTS per site of occlusion are 
summarized in Table 2. NCCT-ASPECTS decreased when there were longer 
delays from symptom onset to image acquisition, while CTASI-ASPECTS 
remained more stable along this time course(Fig. 1). 
Recanalization was achieved in 78/110 patients (71 %); 28/ 92 (30 %) after IVT 
and 50/61 (82 %) after MT; 35/43 (81 %) after combined IVT+MTand 15/18 (83 
%) after primary MT. 
Recanalization rate per site of occlusion was 5/9 (56 %) for ICA, 9/16 (56 %) for 
carotid T-occlusion, 44/58 (76 %) for M1, 15/22 (78 %) for M2, and 5/5 (100 %) 
for tandem occlusions. 
Recanalization was the main predictor of good outcome. Comparisons of 
patients who achieved recanalization with those who did not indicated the 
following: the NIHSS at 24 h was 4 (IQR 1; 9) vs. 17 (IQR 9; 19), p = 0.0001; 
mRS at 3 months was 2 (IQR 0; 3) vs. 3 (IQR 1; 5), p = 0.009; mortality at 90 
days was 6 vs. 22 %, p =0.019; and intracranial symptomatic hemorrhage was 
1 vs. 6 %, p= 0.28, respectively. 
After adjustment for baseline NIHSS score and age, the odds ratio for good 
outcome (mRS 0–2) was 4.3 (95 % CI 1.6–11.4; p= 0.003) for patients who 
achieved recanalization compared with those who did not. CTA-SI-ASPECTS 
was an independent predictor of good outcome only in patients who achieved 
recanalization (OR 2.1; 95 % CI 1.3–3.4; p=0.001) but was not in patients who 
did not achieve recanalization (OR 1.4; 95 % CI 0.9–2.2; p =0.14). NCCT-
ASPECTS was not a predictor of outcome in our study. 
Despite successful recanalization, 22 patients (28 %) had a poor outcome 
(mRS 3–6): 6/27 patients (22 %) treated with IVT, 6/15 treated with MT (40 %), 
and 10/35 who received IVT +MT (29 %). Differences in clinical and radiological 
characteristics between patients with good vs. poor outcomes post-
recanalization are summarized in Table 3. Futile recanalization rate was higher 
among patients with more severe occlusions: 2/5 (40 %) ICA, 6/9 (67 %) T-
thrombus, 2/5 (40 %) tandem occlusions, 10/43 (23 %) M1, and 2/15 (13 %) 
M2. Multivariate logistic regression analyses showed that CTISI-ASPECTS was 
an independent predictor of futile recanalization (OR 0.5; 95 % CI 0.3–0.7; 
p=0.001), while NCCTASPECTS was not (OR 0.8; 95 % CI 0.5–1.2; p=0.3).With 
an AUCROC curve of 0.66 (95 % CI 0.55–0.78), our data define an CTA-SI-
ASPECTS cut-off point ≤5 to predict futile recanalization, with Se of 0.35 (95 % 
CI 0.14–0.62) and Sp of 0.97 (95 % CI 0.86–0.99) and with positive predictive 
value (PPV) and negative predictive value (NPV) of CTA-SIASPECTS 
≤5 of 86 % (95 % CI 42–99.6) and 77 % (95 % CI 62–88), respectively. Figure 2 
shows the optimal AUCROC. 
Eleven patients (14 %) scored 4–6 in the mRS: 2/27 patients treated with IVT (7 
%), 4/15 treated with MT (27 %), and 5/35 who received IVT+MT (14 %). 
Considering this score as a criteria for futile recanalization, CTA-SIASPECTS 
was indeed a better predictor (OR 0.3; 95 % CI 0.15–0.7; p = 0.002). With an 
AUCROC curve of 0.79 (95 %CI 0.63–0.95), the best cut-off point was again a 
score ≤5, with Se of 0.60 (95 % CI 0.26–0.88), Sp of 0.98 (95 % CI 0.88–0.99), 
PPVof 86%(95%CI 42–99.6), and NPVof 92% (95 % CI 80–98). 
Discussion 
Our study identified CTA-SI-ASPECTS as an independent predictor of 
dependency or death despite successful recanalization, i.e., for every point of 
increase in CTA-SI-ASPECTS, the odds of poor outcome (mRS >2) decreases 
50 %. Our data identify a score ≤5 as the best predictive value to forecast futile 
recanalization. MT has been proven to significantly increase the odds of good 
outcome in patients with stroke due to proximal intracranial artery occlusions 
[14–19]. However, some patients may not benefit from treatment, the rate of 
futility being high after MT, especially in cases of larger vessel occlusion. Given 
the high costs of the resources required, it would be important to identify the 
subset of patients who would not benefit from recanalization, in order to avoid 
unnecessary procedures in circumstances such as protracted time lapse from 
symptom onset, existence of comorbidities, or any other in which the indication 
of treatment may be doubtful. 
Clinical prognostic factors such as older age, higherNIHSS score, and longer 
delay between symptom onset and treatment, proposed as markers of futile 
recanalization [1, 2], are not sufficiently discriminatory for treatment decisions. 
Hence, reliable indicators of high probability of futility of treatment are 
necessary in order to facilitate decision-making at the time of patient admission. 
The recently published studies EXTEND-IA [15], ESCAPE [16], and SWIFT-
PRIME [18] demonstrated that the selection of patients for MTon the basis of 
imaging criteria helps improve the odds of good outcomes. 
However, the benefits of additional imaging, such as CT-perfusion, diffusion- 
and perfusion-weighted MRI, or multiphase CTA, beyond NCCTand CTA or 
MRI and MRA for selecting patients for endovascular treatment, are not clear 
[9]. Our results suggest that CTA-SI-ASPECTS on baseline CT study could help 
in making the decision to discard the option of MT since the likelihood of 
success is very low in patients considered as at-risk of futile recanalization 
using the criterion based on CTA-SI-ASPECTS ≤5. Lower sensitivity of this 
cutoff point implies that a number of patients that will not benefit from treatment 
would not be correctly identified, but the high specificity indicates that few 
patients would be falsely classified as at-risk of futile recanalization, thus 
preventing exclusion from treatment of patients that may benefit. The sensitivity 
and the predictive values of CTA-SI-ASPECTS ≤5 increase when considering 
mRS score of 4–6 as poor outcome; this being a more conservative approach 
taking into account that achieving mRS 0–3 could be a good outcome in 
patients suffering from severe strokes. This criterion prevents the exclusion of 
patients who might obtain some benefit from reperfusion, on the basis of 
imaging criteria. NCCT-ASPECTS has also been proposed as a marker of futile 
recanalization [4, 5]. In our study, NCCT-ASPECTS did not appear to be an 
independent predictor of outcome. 
This can be explained, partially, by the majority of our patients having a 
baseline score ≥7. Our data are in accordance with previous studies that 
demonstrated that CTA-SI-ASPECTS detects irreversible damage and predicts 
final infarct extent and neurological outcome with more accuracy than NCCT-
ASPECTS [7, 8]. Our results suggest that CTA-SI-ASPECTS is also superior in 
predicting the futility of recanalization since it is more sensitive in detecting early 
irreversible damage. NCCT-ASPECTS semiquantitatively measures the extent 
of early ischemic changes. The hypo-attenuation observed in NCCT in ischemic 
stroke depends on tissue water content and is, thus, a measure of cytotoxic 
edema in the ischemic brain, which increases linearly with time. Hence, NCCT-
ASPECTS would be higher the shorter the delay from symptom onset to CT 
image acquisition and, as shown in our study, would decrease along with time 
because the ensuing changes are more evident [20]. 
Thus, higher NCCT-ASPECTS scores do not necessarily exclude irreversible 
damage, especially in the very early phase of infarction if there is a short time 
lapse from symptom onset to image acquisition. Conversely, CTA-SI-ASPECTS 
detects regions of the brain with hypo-attenuation due to longer delays, or 
severe reduction in contrast medium arriving in the ischemic brain, i.e., due to 
reduced cerebral blood flow (CBF) and, as such, being an indicator of 
leptomeningeal collateral circulation status and a marker of the degree of 
perfusion at the tissue level [21]. Studies have suggested that patients with 
adequate collateral flow as assessed by CTA are likely to do better after MT 
[16, 22, 23]; collateral supply being responsible for tissue viability. Our study is 
in agreement with these data: lower CTA-SI-ASPECTS were observed in 
patients with larger vessel occlusions (such as carotid T-thrombus) in which 
collateral blood supply through the circle of Willis is more severely jeopardized 
and are associated with poorer outcomes after reperfusion. Since collateral 
status does not depend on time, but more on the individual and the site of 
occlusion, this explains the observation that CTA-SI-ASPECTS appears to be 
less reliant on delay between symptom onset and image acquisition and having 
a better prognostic value, especially at shorter time lapses from stroke onset. 
Thus, CTA-SIASPECTS could be a useful tool to estimate collateral status, and 
a reliable marker of tissue resilience to the ischemic insult. 
The procedure uses a commonly applied CT scoring system which is familiar to 
most clinical practitioners. Dynamic CTA techniques such as multiphase CTA 
are more accurate for the evaluation of collateral status than a single snap shot 
CTA in the arterial phase, since it can detect very delayed pial vessel 
enhancement [6]. In this regard, tandem carotid occlusions or severe stenosis 
(>70 %) may impact on CTA-SI-ASPECTS in such a way that the scoring would 
be reduced due, potentially, to the hemodynamic effect on regional cerebral 
blood flow. 
This is a limitation of this first pass CTA technique in that the reduction of 
collateral supply may be overestimated. Dynamic CTA techniques may help to 
avoid this type of bias. The number of patients with tandem occlusions in our 
study was too small to address this issue. 
It has been suggested that CTA-SI could be a useful tool for estimating 
ischemic core since both CTA-SIASPECTS and cerebral blood volume (CBV) 
ASPECTS, in CT-perfusion maps, correlate with final NCCT-ASPECTS at 24 h 
[24]; CTA-SI-ASPECTS showing the highest sensitivity and specificity for 
predicting final infarct. However, CTA-SI (like other radiological markers) does 
not reflect all the dynamic processes of ischemic injury and may include areas 
of irreversible damage as well as penumbra. As such, the role of imaging-based 
criteria (CTA, CT-perfusion, diffusion MRI) to select patients for reperfusion 
therapies is still to be determined and is an evolving area of clinical 
investigation. 
Our study has some limitations. Firstly, the futility rate in our series of patients is 
quite low compared to previous reports. This could be due to our strict inclusion 
criteria and narrow selection of patients as well as the short delay to 
recanalization. This might miss identifying other possible predictors of futile 
recanalization. 
Conversely, it reinforces the hypothesis that better selection of patients would 
increase efficiency of recanalization therapies. Secondly, image scoring was not 
centralized, and several investigators were responsible for NCCT-ASPECTS as 
well as CTA-SI-ASPECTS. This could have introduced some variability in 
scoring. However, the setting resembles clinical practice in which intra- and 
inter-observer reliability has been shown to be substantial for both scores [25, 
26]. 
Conclusions 
The data from our study indicate that a score for CTASI-ASPECTS between 0 
and 5 is strongly predictive of futile recanalization. This would help select-out 
patients from the application of MT in cases of doubtful benefit. 
However, so as not to miss suitable patients who may benefit from reperfusion 
after MT, the CTA-SIASPECTS score should be combined with other prognostic 
factors in the decision-making process. Further studies are needed to establish 
the role of CTA-SI together with other radiological tools in the selection of stroke 
patients for reperfusion therapies 
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